200 related articles for article (PubMed ID: 28329434)
1. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length.
Mills AC; Badour CL; Korte KJ; Killeen TK; Henschel AV; Back SE
J Trauma Stress; 2017 Apr; 30(2):166-172. PubMed ID: 28329434
[TBL] [Abstract][Full Text] [Related]
2. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
[TBL] [Abstract][Full Text] [Related]
3. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.
Badour CL; Flanagan JC; Gros DF; Killeen T; Pericot-Valverde I; Korte KJ; Allan NP; Back SE
J Consult Clin Psychol; 2017 Mar; 85(3):274-281. PubMed ID: 28221062
[TBL] [Abstract][Full Text] [Related]
4. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.
Gros DF; Lancaster CL; Horner MD; Szafranski DD; Back SE
Compr Psychiatry; 2017 Oct; 78():48-53. PubMed ID: 28803041
[TBL] [Abstract][Full Text] [Related]
5. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized noninferiority clinical trial.
Nacasch N; Huppert JD; Su YJ; Kivity Y; Dinshtein Y; Yeh R; Foa EB
Behav Ther; 2015 May; 46(3):328-41. PubMed ID: 25892169
[TBL] [Abstract][Full Text] [Related]
6. Prolonged Exposure for PTSD in a Veteran group: a pilot effectiveness study.
Smith ER; Porter KE; Messina MG; Beyer JA; Defever ME; Foa EB; Rauch SA
J Anxiety Disord; 2015 Mar; 30():23-7. PubMed ID: 25594370
[TBL] [Abstract][Full Text] [Related]
7. Emotional Processing of Imaginal Exposures Predicts Symptom Improvement: Therapist Ratings Can Assess Trajectory in Prolonged Exposure for Posttraumatic Stress Disorder.
Cox KS; Wangelin BC; Keller SM; Lozano BE; Murphy MM; Maher EK; Cobb AR; Tuerk PW
J Trauma Stress; 2020 Jun; 33(3):338-344. PubMed ID: 32103546
[TBL] [Abstract][Full Text] [Related]
8. Behavioral activation and therapeutic exposure: an investigation of relative symptom changes in PTSD and depression during the course of integrated behavioral activation, situational exposure, and imaginal exposure techniques.
Gros DF; Price M; Strachan M; Yuen EK; Milanak ME; Acierno R
Behav Modif; 2012 Jul; 36(4):580-99. PubMed ID: 22679240
[TBL] [Abstract][Full Text] [Related]
9. Prolonged Exposure Therapy With Veterans and Active Duty Personnel Diagnosed With PTSD and Traumatic Brain Injury.
Wolf GK; Kretzmer T; Crawford E; Thors C; Wagner HR; Strom TQ; Eftekhari A; Klenk M; Hayward L; Vanderploeg RD
J Trauma Stress; 2015 Aug; 28(4):339-47. PubMed ID: 26201688
[TBL] [Abstract][Full Text] [Related]
10. Differential relations between breathing retraining, in vivo exposure, and imaginal exposure homework completion and treatment outcomes in veterans receiving prolonged exposure for PTSD.
Gros DF; Pavlacic JM; Argyriou E; Acierno R; Hernandez-Tejada MA
J Clin Psychol; 2024 Jun; 80(6):1259-1270. PubMed ID: 38367254
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD.
Thorp SR; Glassman LH; Wells SY; Walter KH; Gebhardt H; Twamley E; Golshan S; Pittman J; Penski K; Allard C; Morland LA; Wetherell J
J Anxiety Disord; 2019 May; 64():45-54. PubMed ID: 30978622
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Prolonged Exposure therapy for veterans with posttraumatic stress disorder.
Goodson JT; Lefkowitz CM; Helstrom AW; Gawrysiak MJ
J Trauma Stress; 2013 Aug; 26(4):419-25. PubMed ID: 23934939
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.
Szafranski DD; Gros DF; Acierno R; Brady KT; Killeen TK; Back SE
Clin Psychol Psychother; 2019 Mar; 26(2):218-226. PubMed ID: 30419153
[TBL] [Abstract][Full Text] [Related]
14. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.
Jarnecke AM; Allan NP; Badour CL; Flanagan JC; Killeen TK; Back SE
Addict Behav; 2019 Mar; 90():35-39. PubMed ID: 30355535
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of national implementation of prolonged exposure therapy in Veterans Affairs care.
Eftekhari A; Ruzek JI; Crowley JJ; Rosen CS; Greenbaum MA; Karlin BE
JAMA Psychiatry; 2013 Sep; 70(9):949-55. PubMed ID: 23863892
[TBL] [Abstract][Full Text] [Related]
16. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness.
Gandelman EM; Miller SA; Back SE
J Trauma Stress; 2022 Apr; 35(2):682-693. PubMed ID: 34979039
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
[TBL] [Abstract][Full Text] [Related]
18. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study.
Flanagan JC; Fischer MS; Badour CL; Ornan G; Killeen TK; Back SE
J Dual Diagn; 2017; 13(3):213-218. PubMed ID: 28541802
[TBL] [Abstract][Full Text] [Related]
19. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
[TBL] [Abstract][Full Text] [Related]
20. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial.
Mills KL; Teesson M; Back SE; Brady KT; Baker AL; Hopwood S; Sannibale C; Barrett EL; Merz S; Rosenfeld J; Ewer PL
JAMA; 2012 Aug; 308(7):690-9. PubMed ID: 22893166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
